Rates of severe neutropenia and infection risk in patients treated with deferiprone: 28 years of data

MLA

Badawy, Sherif M., et al. “Rates of Severe Neutropenia and Infection Risk in Patients Treated with Deferiprone: 28 Years of Data.” Blood Advances, vol. 8, no. 21, Nov. 2024, pp. 5641–49. EBSCOhost, https://doi.org/10.1182/bloodadvances.2023012316.

APA

Badawy, S. M., Palmblad, J., Tricta, F., Toiber Temin, N., Fradette, C., Lin, L., Rozova, A., & Sheth, S. (2024). Rates of severe neutropenia and infection risk in patients treated with deferiprone: 28 years of data. Blood Advances, 8(21), 5641–5649. https://doi.org/10.1182/bloodadvances.2023012316

Chicago

Badawy, Sherif M., Jan Palmblad, Fernando Tricta, Noemi Toiber Temin, Caroline Fradette, Leo Lin, Anna Rozova, and Sujit Sheth. 2024. “Rates of Severe Neutropenia and Infection Risk in Patients Treated with Deferiprone: 28 Years of Data.” Blood Advances 8 (21): 5641–49. doi:10.1182/bloodadvances.2023012316.